Activation of the AKT pathway and outcomes in patients (pts) treated with or without ipatasertib (ipat) in metastatic castration-resistant prostate cancer (mCRPC): Next-generation sequencing (NGS) ...
Evaluation of quality-of-life side effects and duration of therapy in a phase III study of intermittent monotherapy versus continuous combined androgen deprivation No significant financial ...
Scientists have discovered a new way to boost muscle strength without the dangerous side effects of traditional androgens. A powerful male hormone called 5α-DHT normally drives bone density and muscle ...
Androgen receptor (AR) signaling affects response to BRAF/MEK inhibitor therapy in both males and females with melanoma, researchers have shown. The findings provide a new target to combat therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results